Drug interactions with emtricitab-rilpivirine-tenofov oral and lansoprazole iv

emtricitab-rilpivirine-tenofov oral brand names and other generic formulations include:

Complera Oral

All generic drug interactions for emtricitab-rilpivirine-tenofov oral (lists will include brand and generic names):

lansoprazole iv brand names and other generic formulations include:

Prevacid IV IV

All generic drug interactions for lansoprazole iv (lists will include brand and generic names):
ContraindicatedNever use this combination of drugs because of high risk for dangerous interaction

emtricitab-rilpivirine-tenofov oral and lansoprazole iv

emtricitab-rilpivirine-tenofov oral decreases levels of lansoprazole iv by altering drug metabolism. Do not use together; Taking these drugs together may cause treatment failure and/or the development of rilpivirine or NNRTI resistance.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
ContraindicatedNever use combination.

emtricitab-rilpivirine-tenofov oral and lansoprazole iv

emtricitab-rilpivirine-tenofov oral decreases levels of lansoprazole iv by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Concurrent use may cause treatment failure and/or the development of rilpivirine or NNRTI resistance. Coadministration of a PPI and rilpivirine may result in decreased rilpivirine plasma concentrations, which could cause impaired virologi

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.
ContraindicatedNever use this combination of drugs because of high risk for dangerous interaction

lansoprazole iv and emtricitab-rilpivirine-tenofov oral

lansoprazole iv decreases levels of emtricitab-rilpivirine-tenofov oral by altering drug metabolism. Do not use together; Taking these drugs together may cause treatment failure and/or the development of rilpivirine or NNRTI resistance.

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
ContraindicatedNever use combination.

lansoprazole iv and emtricitab-rilpivirine-tenofov oral

lansoprazole iv decreases levels of emtricitab-rilpivirine-tenofov oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Concurrent use may cause treatment failure and/or the development of rilpivirine or NNRTI resistance. Coadministration of a PPI and rilpivirine may result in decreased rilpivirine plasma concentrations, which could cause impaired virologi

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.

Check for more interactions with the Drug Interaction Checker

Drug Interaction Categories

Contraindicated

Never use this combination of drugs because of high risk for dangerous interaction

Serious

Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

Significant

Potential for significant interaction (monitoring by your doctor is likely required)

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD